FDA Drug Shortages (New and Updated) - September 20, 2021

You are subscribed to Drug Shortages for U.S. Food and Drug Administration. This information has recently been updated, and is now available. FDA Drug Shortages Atropine Sulfate Ophthalmic Ointment (Updated - Resolved) Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage) Chlordiazepoxide Hydrochloride Capsules (Updated - Currently in Shortage) Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage) Dexmedetomidine Injection (Updated - Currently in Shortage) Epinephrine Injection, Auto-Injector (Updated - Currently in Shortage) Famotidine Tablets (Updated - Currently in Shortage) Guanfacine Hydrochloride Tablets (Updated - Currently in Shortage) Histreline Acetate Implant (New - Discontinuation) Hydromorphone Hydrochloride Injection (Updated - Currently in Shortage) Ketamine Injection (Updated - Currently in Shortage) Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage) Loxapine Capsules (Updated - Currently in Shortage) Nefazodone Hydrochloride Tablets (Updated - Currently in Shortage) Nizatidine Capsules (Updated - Currently in Shortage) Propofol Injectable Emulsion (Updated - Currently in Shortage) Sulfasalazine Tablets (Updated - Currently in Shortage) Vecuronium Bromide for Injection (Updated - Currently in Shortage) Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA